Be Part of the Solution
GRx+Biosims 2019 is the premier scientific and regulatory event for the U.S. generics and biosimilars industries, featuring timely programming relevant to technical, regulatory, policy and legal professionals. Top officials and subject matter experts share their knowledge and best practices to help attendees understand how to succeed in generic and biosimilar development, the regulatory process and approvals, and the evolving policy landscape.
Showcase your company at GRx+Biosims 2019. Don’t miss out on this highly interactive and professional business environment in which industry vendors can meet generic and biosimilars industry executives. We offer our exhibitors abundant networking time with industry decision-makers. Reserve your space today!
AAM will host a variety of exciting professional networking opportunities, which include a welcome reception, breakfasts, luncheons, morning and afternoon refreshment breaks, and dinner and entertainment on Tuesday, November 5.
Cancellations must be received in writing either faxed to 202-249-7105 or emailed to firstname.lastname@example.org by Monday, October 21, 2019, and confirmed by AAM. All cancellations are subject to a $300 processing fee. No refunds after October 21, 2019.
Raise your company profile by participating in this prestigious event. For more information contact Jennifer Soup at email@example.com.
Bethesda North Marriott Hotel and Conference Center
5701 Marinelli Road North
Bethesda, MD 20852
Reservations must be made directly with the Bethesda North Marriott Hotel and Conference Center by calling 1-800-859-8003 or online by clicking here. Please refer to the meeting name: “GRx+Biosims” to obtain the preferred rate. Only a limited number of preferred rate rooms are available. The preferred rate cutoff date is October 11, 2019. After this date or after the preferred rate rooms are sold out rooms are subject to hotel rates and availability.
Complimentary self-parking validation will be provided to GRx+Biosims attendees.
Learn how your generic and biosimilar industry is committed to your health.